Jonty Brown became one of the first people to get an "artificial pancreas" from the NHS - and is now an ultramarathon runner.

Expands TempraMed's product portfolio and adds a digital component to track and record medication use. First in the world platform that turns almost every insulin and GLP-1 pens to be connected and ...

Roughly half of Americans have prediabetes or diabetes, including an increasing number of children. High blood levels of ...

Fathers exposed to microplastics before conception may be setting their daughters up for metabolic problems later in life.

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

The commonwealth claims that pharmacy benefit managers and drug manufacturers are in cahoots to inflate insulin prices for ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

RANCHO CUCAMONGA, CA / / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and ...

Second-generation automated insulin delivery (AID) systems improve glycemic control and treatment satisfaction in type 1 diabetes.

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...